Regulation of extracellular adenosine levels in the striatum of aging rats
- PMID: 7583197
- DOI: 10.1016/0006-8993(95)00471-2
Regulation of extracellular adenosine levels in the striatum of aging rats
Abstract
Extracellular adenosine concentrations, evaluated by microdialysis in the striatum of young and aged rats, were 66.8 +/- 0.7 and 71.6 +/- 1.0 nM, respectively. The adenosine deaminase inhibitor EHNA (100 microM) increased the extracellular adenosine levels in young rats only. The adenosine kinase inhibitor iodotubercidin (10 microM) brought about the same increase in young and aged rats. In aged rats the resting adenosine outflow was reduced by the N-methyl-D-aspartate (NMDA) receptor antagonist D-(-)-2-amino-7-phophonoheptanoic acid (D-AP7) (1 mM). It is concluded that extracellular levels of adenosine in the striatum are not affected by age, irrespective of the differences in adenosine deaminase activity and that the release of excitatory amino acids is responsible for much of resting adenosine outflow in aged but not in young rats.
Similar articles
-
Effect of K+ depolarization, tetrodotoxin, and NMDA receptor inhibition on extracellular adenosine levels in rat striatum.Eur J Pharmacol. 1993 Mar 30;234(1):61-5. doi: 10.1016/0014-2999(93)90706-n. Eur J Pharmacol. 1993. PMID: 8472761
-
Increases in interstitial adenosine and cerebral blood flow with inhibition of adenosine kinase and adenosine deaminase.J Cereb Blood Flow Metab. 1993 Mar;13(2):201-7. doi: 10.1038/jcbfm.1993.24. J Cereb Blood Flow Metab. 1993. PMID: 8436611
-
Dual cardiac microdialysis to assess drug-induced changes in interstitial purine metabolites: adenosine deaminase inhibition versus adenosine kinase inhibition.Cardiovasc Res. 1998 Jan;37(1):171-8. doi: 10.1016/s0008-6363(97)00213-7. Cardiovasc Res. 1998. PMID: 9539871
-
Co-administration of adenosine kinase and deaminase inhibitors produces supra-additive potentiation of N-methyl-D-aspartate-evoked adenosine formation in cortex.Eur J Pharmacol. 1998 Mar 5;344(2-3):121-5. doi: 10.1016/s0014-2999(97)01582-3. Eur J Pharmacol. 1998. PMID: 9600645
-
Can adenosine deaminase inhibitors be cytoprotective agents?Adv Exp Med Biol. 1998;431:395-9. doi: 10.1007/978-1-4615-5381-6_79. Adv Exp Med Biol. 1998. PMID: 9598099 Review. No abstract available.
Cited by
-
Adenosine Kinase Isoforms in the Developing Rat Hippocampus after LiCl/Pilocarpine Status Epilepticus.Int J Mol Sci. 2022 Feb 24;23(5):2510. doi: 10.3390/ijms23052510. Int J Mol Sci. 2022. PMID: 35269653 Free PMC article.
-
Purinoceptors in the Central Nervous System.Drug Dev Res. 1996 Nov-Dec;39(3-4):361-370. doi: 10.1002/(sici)1098-2299(199611/12)39:3/4<361::aid-ddr17>3.0.co;2-4. Drug Dev Res. 1996. PMID: 38283105 Free PMC article.
-
Adenosine Kinase Inhibition Protects against Cranial Radiation-Induced Cognitive Dysfunction.Front Mol Neurosci. 2016 Jun 3;9:42. doi: 10.3389/fnmol.2016.00042. eCollection 2016. Front Mol Neurosci. 2016. PMID: 27375429 Free PMC article.
-
Role of Adenosine in Epilepsy and Seizures.J Caffeine Adenosine Res. 2020 Jun 1;10(2):45-60. doi: 10.1089/caff.2019.0022. Epub 2020 Jun 4. J Caffeine Adenosine Res. 2020. PMID: 32566903 Free PMC article. Review.
-
Homeostatic control of brain function - new approaches to understand epileptogenesis.Front Cell Neurosci. 2013 Jul 16;7:109. doi: 10.3389/fncel.2013.00109. eCollection 2013. Front Cell Neurosci. 2013. PMID: 23882181 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials